ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK plus non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)

Solomon, B. J.Wu, Y-L.Dziadziuszko, R.Barlesi, F.Nishio, M.Ahn, J. S.Horinouchi, H.2026-04-042026-04-0420240923-75341569-8041https://doi.org/10.1016/j.annonc.2024.08.1265https://hdl.handle.net/11616/109700Annual Congress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 13-17, 2024 -- Barcelona, SPAIN[No abstract available]eninfo:eu-repo/semantics/openAccessALINA: Exploratory biomarker analyses in patients (pts) with resected ALK plus non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)Conference Object35S775S77510.1016/j.annonc.2024.08.1265WOS:001326612901509Q1